| Indicators | Browse All

OraSure Technologies, Inc. (OSUR)

Healthcare | Medical Instruments & Supplies | Bethlehem, United States | NasdaqGS
3.71 USD -0.10 (-2.625%) ⇩ (Oct. 14, 2026, 4 p.m. EDT)
After hours: 3.71

Short-term:★★☆☆☆Long-term:★☆☆☆☆Dividends:☆☆☆☆☆
Hot Take ↕ | Oct. 10, 2026, 4:06 a.m. EDT

The investment case for OraSure is fundamentally broken, making it a dangerous long-term hold despite the speculative frenzy in the options market. The business is generating negative free cash flow and operating losses, with revenue shrinking by nearly 2% annually. The multi-year price trajectory confirms this deterioration, showing a massive 63% decline over the last nine years, capped by two consecutive years of falling prices. While the stock trades at a discount to book value, the negative earnings and cash burn suggest the market has already priced in a severe value trap. However, the disconnect between reality and sentiment is stark. The options chain tells a story of aggressive speculation, with traders pouring capital into calls while ignoring the bleak fundamentals. This creates a volatile short-term environment where the stock could bounce on hype or catalysts, but the lack of a profitable core business makes any rally fragile. For a serious investor, the deteriorating fundamentals and lack of cash generation warrant avoidance, regardless of the temporary optimism driving the options flow.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoTheta ✓0.073516
AutoETS0.074682
MSTL0.076456
AutoARIMA0.086627

Forecast horizon: 45 days | Selected: AutoTheta

Forecast Reliability
Score 39%
H-stat 10.63
Ljung-Box p 0.000
Jarque-Bera p 0.315
Excess Kurtosis -0.70
Attribute Value
Sector Healthcare
Last Dividend Date 1998-01-07
Debt to Equity Ratio 3.806
Revenue per Share 1.588
Market Cap 255,873,600
Forward P/E -5.62
Beta 1.02
Profit Margins -43.70%
Website https://www.orasure.com

As of Oct. 10, 2026, 4:06 a.m. EDT: Speculators are overwhelmingly bullish, with open interest concentrated almost entirely in out-of-the-money calls (OTM OI % > 95% across expirations). There is virtually no put activity, indicating a lack of hedging or bearish positioning. The heavy concentration of call volume at strikes significantly above the current price suggests a speculative bet on a substantial price rebound, despite the underlying company's poor fundamentals.


Dividend Data

Dividend History
Date Dividend Yield %
1998-01-08 1.6 30.843373
Additional Data
dividendYield 0.0
trailingAnnualDividendRate 0.0
trailingAnnualDividendYield 0.0
lastDividendValue 1.6
lastDividendDate 1998-01-08

Info Dump

Attribute Value
52 Week Change 0.21241832
Address1 220 East First Street
All Time High 27.5
All Time Low 1.791667
Ask 4.9
Ask Size 2
Audit Risk 4
Average Daily Volume10 Day 470,300
Average Daily Volume3 Month 494,878
Average Volume 494,878
Average Volume10Days 470,300
Beta 1.024
Bid 2.79
Bid Size 2
Board Risk 2
Book Value 4.608
City Bethlehem
Compensation As Of Epoch Date 1,767,139,200
Compensation Risk 1
Country United States
Crypto Tradeable 0
Currency USD
Current Price 3.71
Current Ratio 8.875
Custom Price Alert Confidence HIGH
Date Short Interest 1,790,726,400
Day High 3.81
Day Low 3.71
Debt To Equity 3.806
Display Name OraSure
Dividend Yield 0.0
Earnings Call Timestamp End 1,785,963,600
Earnings Call Timestamp Start 1,785,963,600
Earnings Timestamp 1,785,960,000
Earnings Timestamp End 1,793,822,400
Earnings Timestamp Start 1,793,822,400
Ebitda -61,556,000
Ebitda Margins -0.54759
Enterprise To Ebitda -1.745
Enterprise To Revenue 0.955
Enterprise Value 107,385,608
Eps Current Year -0.8
Eps Forward -0.66
Eps Trailing Twelve Months -0.69
Esg Populated 0
Exchange NMS
Exchange Data Delayed By 15
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 3.7474
Fifty Day Average Change -0.037400007
Fifty Day Average Change Percent -0.009980255
Fifty Two Week Change Percent 21.241833
Fifty Two Week High 4.58
Fifty Two Week High Change -0.8699999
Fifty Two Week High Change Percent -0.1899563
Fifty Two Week Low 2.08
Fifty Two Week Low Change 1.6300001
Fifty Two Week Low Change Percent 0.7836539
Fifty Two Week Range 2.08 - 4.58
Financial Currency USD
First Trade Date Milliseconds 532,621,800,000
Float Shares 56,943,257
Forward Eps -0.66
Forward P E -5.621212
Free Cashflow -44,569,624
Full Exchange Name NasdaqGS
Full Time Employees 500
Fullday Change -0.099999905
Fullday Change Percent -2.6246696
Fullday Price 3.71
Gmt Off Set Milliseconds -14,400,000
Governance Epoch Date 1,790,812,800
Gross Margins 0.42633998
Gross Profits 47,926,000
Has Pre Post Market Data 1
Held Percent Insiders 0.06486
Held Percent Institutions 0.89001
Implied Shares Outstanding 68,968,627
Industry Medical Instruments & Supplies
Industry Disp Medical Instruments & Supplies
Industry Key medical-instruments-supplies
Ir Website http://phx.corporate-ir.net/phoenix.zhtml?c=99740&p=irol-irhome
Is Earnings Date Estimate 0
Language en-US
Last Dividend Date 884,217,600
Last Dividend Value 1.6
Last Fiscal Year End 1,767,139,200
Last Split Date 544,838,400
Last Split Factor 3:1
Long Business Summary OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, sells, and distributes diagnostic products and specimen collection devices in the United States, Europe, Africa, and internationally. It offers OraQuick Rapid HIV test, OraQuick HIV self-test, OraQuick HIV self-test(international), OraQuick HCV rapid antibody test and self-test, Syphilis health check rapid diagnostic test, OraQuick Ebola rapid antigen test, InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, SickleSCAN test, and OraSure oral fluid collection device for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D. saliva alcohol test. The company also provides genomic products under the Oragene and ORAcollect brands for collecting genetic material from human saliva; Colli-Pee collection devices for the volumetric collection of urine samples; and HEMAcollect protein blood collection device. In addition, it provides microbiome products, such as OMNIgene GUT for self-collecting microbial DNA from feces or stool samples for gut microbiome profiling; OMNIgene GUT DNA and RNA collection devices; OMNIgene SALIVA DNA and RNA collection devices; and OMNIgene GUT Dx collection device for collection of human fecal samples and the stabilization of DNA from the bacterial community. Further, it offers other diagnostic products, such as immunoassays and other in vitro diagnostic tests. Additionally, it develops a molecular self-test for chlamydia trachomatis and neisseria gonorrhoeae. It sells its products to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, commercial and industrial entities, disease risk management, diagnostics, pharmaceutical, biotech, and companion animal, markets. The company was founded in 1987 and is headquartered in Bethlehem, Pennsylvania.
Long Name OraSure Technologies, Inc.
Market us_market
Market Cap 255,873,600
Market State POSTPOST
Max Age 86,400
Message Board Id finmb_540470
Most Recent Quarter 1,782,777,600
Net Income To Common -49,126,000
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 275,184,821
Number Of Analyst Opinions 1
Open 3.77
Operating Cashflow -42,883,000
Operating Margins -0.55984
Overall Risk 2
Payout Ratio 0.0
Peg Ratio 6.19
Phone 610 882 1820
Post Market Change 0.0
Post Market Change Percent 0.0
Post Market Price 3.71
Post Market Time 1,792,008,096
Previous Close 3.81
Price Eps Current Year -4.6375
Price Hint 4
Price To Book 0.80512154
Price To Sales Trailing12 Months 2.2762125
Profit Margins -0.43702
Quick Ratio 7.482
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key none
Region US
Regular Market Change -0.0999999
Regular Market Change Percent -2.62467
Regular Market Day High 3.81
Regular Market Day Low 3.71
Regular Market Day Range 3.71 - 3.81
Regular Market Open 3.77
Regular Market Previous Close 3.81
Regular Market Price 3.71
Regular Market Time 1,792,008,001
Regular Market Volume 355,981
Return On Assets -0.110360004
Return On Equity -0.14066
Revenue Growth -0.019
Revenue Per Share 1.588
Sand P52 Week Change 0.1570785
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Share Holder Rights Risk 4
Shares Outstanding 68,968,627
Shares Percent Shares Out 0.0425
Shares Short 2,930,877
Shares Short Previous Month Date 1,788,134,400
Shares Short Prior Month 3,130,085
Short Name OraSure Technologies, Inc.
Short Percent Of Float 0.044699997
Short Ratio 4.88
Source Interval 15
State PA
Symbol OSUR
Target High Price 4.0
Target Low Price 4.0
Target Mean Price 4.0
Target Median Price 4.0
Total Cash 160,582,000
Total Cash Per Share 2.328
Total Debt 12,094,000
Total Revenue 112,412,000
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -0.69
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 3.43125
Two Hundred Day Average Change 0.27874994
Two Hundred Day Average Change Percent 0.0812386
Type Disp Equity
Volume 355,981
Website https://www.orasure.com
Zip 18,015